PHC Holdings Corp. (2GY) Stock Price & Analysis
2GY Stock Chart & Stats
- Day’s Range
- EUR 7.80 - EUR 7.80
- 52-Week Range
- EUR 4.96 - EUR 9.20
- Previous Close
- EUR 7.50
- Volume
- N/A
- Average Volume (3M)
- 20
- Market Cap
- EUR 1.02B
- Enterprise Value
- EUR 317.86B
- Total Cash (Recent Filing)
- EUR 41.28B
- Total Debt (Recent Filing)
- EUR 229.26B
- Price to Earnings (P/E)
- 19.5
- Beta
- 0.62
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- 0.26
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.93%
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation
PHC generates substantial operating and free cash flow despite thin reported earnings, indicating healthy cash conversion from its healthcare operations. Sustained cash production can support debt service, ongoing investment, and customer support while providing resilience across the next several quarters.
Stable Gross Margins
Consistent gross margins of roughly 45–48% indicate that PHC retains reasonable product economics across its medical devices, diagnostics, and healthcare equipment portfolio. Margin stability provides a durable foundation for operating investment and potential earnings recovery if profitability improves.
Recurring Consumables And Services
PHC combines capital equipment sales with repeat demand for diagnostic reagents, diabetes test strips, and after-sales services. This installed-base model can deepen customer relationships and make part of revenue more recurring than one-time equipment purchases alone.
Bears Say
Near-Breakeven Net Profitability
Very thin net profitability shows that PHC is not consistently converting solid gross margins and positive operating earnings into durable bottom-line returns. This limits internal capital formation and leaves earnings more vulnerable to cost, financing, or operating pressures.
Elevated Leverage
Although leverage has improved from prior years, debt remains high for a medical devices company and operating cash flow covers only a modest portion of total debt. This constrains financial flexibility and can limit investment capacity while profitability remains weak.
Limited Revenue Growth
Revenue growth remains modest rather than demonstrating strong expansion across PHC’s healthcare markets. A largely stable top line makes future earnings improvement more dependent on efficiency and margin gains, while limiting the operating leverage available from faster sales growth.
PHC Holdings Corp. News
2GY FAQ
What was PHC Holdings Corp.’s price range in the past 12 months?
What is PHC Holdings Corp.’s market cap?
When is PHC Holdings Corp.’s upcoming earnings report date?
How were PHC Holdings Corp.’s earnings last quarter?
Is PHC Holdings Corp. overvalued?
Does PHC Holdings Corp. pay dividends?
What is PHC Holdings Corp.’s EPS estimate?
How many shares outstanding does PHC Holdings Corp. have?
What happened to PHC Holdings Corp.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PHC Holdings Corp.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PHC Holdings Corp.
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kyoko Deguchi
- Employees
- 8,647
- Website
- www.phchd.com/jp
- Address
- Dai-ichi Life Hibiya First, Tokyo, 100-8403, JP
PHC Holdings Corp. (2GY) Earnings & Revenues
2GY Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 4 | 2 |
| Technical Analysis | 3 | 4 | 2 |
| Moving Averages | 12 | 0 | 0 |


